Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma
EJNMMI Res
.
2024 Aug 22;14(1):74.
doi: 10.1186/s13550-024-01134-1.
Authors
Lindsay K Dickerson
1
,
Adrienne L Lehnert
2
,
Donald K Hamlin
3
,
Kevin P Labadie
1
,
Kristin E Goodsell
1
,
Yongjun Liu
4
,
Yawen Li
3
,
D Scott Wilbur
3
,
Robert Miyaoka
2
,
James O Park
5
6
Affiliations
1
Department of Surgery, University of Washington, 1959 NE Pacific St., Box 356410, Seattle, WA, 98195, USA.
2
Department of Radiology, University of Washington, Seattle, WA, USA.
3
Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
4
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
5
Department of Surgery, University of Washington, 1959 NE Pacific St., Box 356410, Seattle, WA, 98195, USA.
[email protected]
.
6
Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, USA.
[email protected]
.
PMID:
39174756
PMCID:
PMC11341507
DOI:
10.1186/s13550-024-01134-1
No abstract available
Grants and funding
P30 CA015704/CA/NCI NIH HHS/United States
CA015704/Foundation for the National Institutes of Health